Literature DB >> 1464728

Technetium-labeled myocardial imaging agents.

A S Iskandrian1, J Heo.   

Abstract

99mTc sestamibi and 99mTc teboroxime has unique features that differ from thallium-201 in dosimetry, energy, cellular transport, extraction fraction, retention, washout, and imaging protocols. Sestamibi is ideal for gated and SPECT imaging while SPECT imaging with a multi-head detector system is preferred for teboroxime. Both permit simultaneous assessment of perfusion and function using first-pass radionuclide angiography. This paper discusses the special features and clinical applications of these two technetium agents.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1464728     DOI: 10.1007/bf01146027

Source DB:  PubMed          Journal:  Int J Card Imaging        ISSN: 0167-9899


  48 in total

Review 1.  Current and emerging scintigraphic methods to assess myocardial viability and their clinical importance.

Authors:  A S Iskandrian; J Heo; T Nguyen
Journal:  Am J Card Imaging       Date:  1992-03

2.  Myocardial perfusion imaging with technetium-99m SQ30217: comparison with thallium-201 and coronary anatomy.

Authors:  D W Seldin; L L Johnson; D K Blood; M J Muschel; K F Smith; R M Wall; P J Cannon
Journal:  J Nucl Med       Date:  1989-03       Impact factor: 10.057

3.  Technetium-99m isonitrile myocardial uptake at rest. II. Relation to clinical markers of potential viability.

Authors:  T P Rocco; V Dilsizian; H W Strauss; C A Boucher
Journal:  J Am Coll Cardiol       Date:  1989-12       Impact factor: 24.094

4.  Serial quantitative planar technetium-99m isonitrile imaging in acute myocardial infarction: efficacy for noninvasive assessment of thrombolytic therapy.

Authors:  F J Wackers; R J Gibbons; M S Verani; D S Kayden; P A Pellikka; T Behrenbeck; J J Mahmarian; B L Zaret
Journal:  J Am Coll Cardiol       Date:  1989-10       Impact factor: 24.094

5.  Relationship between regional myocardial blood flow and the distribution of 99mTc-sestamibi in the presence of total coronary artery occlusion.

Authors:  S A Mousa; J M Cooney; S J Williams
Journal:  Am Heart J       Date:  1990-04       Impact factor: 4.749

6.  A neutral technetium-99m complex for myocardial imaging.

Authors:  R K Narra; A D Nunn; B L Kuczynski; T Feld; P Wedeking; W C Eckelman
Journal:  J Nucl Med       Date:  1989-11       Impact factor: 10.057

7.  Comparison of thallium-201 and technetium-99m hexakis 2-methoxyisobutyl isonitrile single-photon emission computed tomography for estimating the extent of myocardial ischemia and infarction in coronary artery disease.

Authors:  K A Narahara; J Villanueva-Meyer; C J Thompson; M Brizendine; I Mena
Journal:  Am J Cardiol       Date:  1990-12-15       Impact factor: 2.778

8.  Tomographic myocardial perfusion imaging with technetium-99m-teboroxime at rest and after dipyridamole.

Authors:  Q S Li; G Solot; T L Frank; H N Wagner; L C Becker
Journal:  J Nucl Med       Date:  1991-10       Impact factor: 10.057

9.  Demonstration of reperfusion after thrombolysis with technetium-99m isonitrile myocardial imaging.

Authors:  D S Kayden; J A Mattera; B L Zaret; F J Wackers
Journal:  J Nucl Med       Date:  1988-11       Impact factor: 10.057

10.  Technetium-99m methoxyisobutyl isonitrile (RP30) for quantification of myocardial ischemia and reperfusion in dogs.

Authors:  Q S Li; T L Frank; D Franceschi; H N Wagner; L C Becker
Journal:  J Nucl Med       Date:  1988-09       Impact factor: 10.057

View more
  1 in total

1.  Myocardial clearance of technetium-99m-teboroxime in reperfused injured canine myocardium.

Authors:  David R Okada; Gerald Johnson; Robert D Okada
Journal:  EJNMMI Res       Date:  2014-08-01       Impact factor: 3.138

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.